Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ROPINIROLE HCL ER 6 MG TABLET

ropinirole
$0.9407per EA

Strength

6 mg/1

Manufacturer

Solco Healthcare US LLC

NDC

43547055603

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ROPINIROLE

Approval Type

Generic (ANDA)

FDA Application

ANDA204413

On Market Since

3/22/2022

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price History

1W

0.0%

1M

-7.9%

3M

-15.4%

6M

-3.1%

1Y

-27.8%

3Y

-35.8%

5Y

N/A

All

-3.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

PRAMIPEXOLE 0.125 MG TABLET
Generic
13668009105•Torrent Pharmaceuticals Limited
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
13668009190•Torrent Pharmaceuticals Limited
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
50228012610•ScieGen Pharmaceuticals Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
57237018090•Rising Pharma Holdings Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
64380074605•Strides Pharma Inc.
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
68462033090•Glenmark Pharmaceuticals Inc., USA
$0.0425
per EA
PRAMIPEXOLE 0.125 MG TABLET
Generic
65862060490•Aurobindo Pharma Limited
$0.0427
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
43547026910•Solco Healthcare US LLC
$0.0433
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
43547026950•Solco Healthcare US LLC
$0.0433
per EA
ROPINIROLE HCL 0.5 MG TABLET
Generic
50268074215•AvPAK
$0.0433
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy